J. Lucas

Antibody-mediated rejection in kidney transplantation: an update

K. Sureshkumar, J. Lucas, Jeannie P Co, 2011, Expert opinion on pharmacotherapy.

Diverse alterations associated with resistance to KRAS(G12C) inhibition

M. Berger, J. Reis-Filho, B. Weigelt, 2021, Nature.

A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis.

R. Abraham, J. Gibbons, L. Toral-Barza, 2008, Cancer research.

Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS

Mallika Singh, R. Nichols, Y. Pourfarjam, 2023, Science.

A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis.

R. Abraham, J. Gibbons, Ker Yu, 2008, Cancer research.